rc 3095 has been researched along with cetrorelix in 4 studies
| Studies (rc 3095) | Trials (rc 3095) | Recent Studies (post-2010) (rc 3095) | Studies (cetrorelix) | Trials (cetrorelix) | Recent Studies (post-2010) (cetrorelix) |
|---|---|---|---|---|---|
| 108 | 2 | 26 | 609 | 157 | 157 |
| Protein | Taxonomy | rc 3095 (IC50) | cetrorelix (IC50) |
|---|---|---|---|
| Gonadotropin-releasing hormone receptor | Homo sapiens (human) | 0.0042 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, RZ; Groot, K; Halmos, G; O'Byrne, K; Pinski, J; Schally, AV; Szepeshazi, K | 1 |
| Groot, K; Halmos, G; Pinski, J; Radulovic, S; Schally, AV; Szepeshazi, K; Yano, T | 1 |
| Armatis, P; Chatzistamou, I; Schally, AV; Sun, B; Szepeshazi, K | 1 |
| Arencibia, JM; Chatzistamou, I; Groot, K; Hebert, F; Schally, AV; Szepeshazi, K | 1 |
4 other study(ies) available for rc 3095 and cetrorelix
| Article | Year |
|---|---|
Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Binding Sites; Body Weight; Bombesin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Gastrin-Releasing Peptide; Gastrins; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Transplantation; Peptide Fragments; Peptides; Receptors, Somatotropin; Somatostatin; Substrate Specificity; Transplantation, Heterologous | 1994 |
Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice.
Topics: Animals; Antineoplastic Agents; Bombesin; Breast Neoplasms; Cell Division; Epidermal Growth Factor; Female; Gonadotropin-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Luteinizing Hormone; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Tumor Cells, Cultured | 1994 |
Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.
Topics: Animals; Antineoplastic Agents; Bombesin; Cell Division; Epithelium; Female; Gastrin-Releasing Peptide; Gene Expression; Genes, fos; Genes, jun; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Peptide Fragments; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Receptors, Bombesin; RNA, Messenger; Tumor Cells, Cultured | 2000 |
Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix.
Topics: Adenocarcinoma, Clear Cell; Animals; Antineoplastic Agents, Hormonal; Bombesin; ErbB Receptors; Female; Gastrin-Releasing Peptide; Gene Expression Regulation, Neoplastic; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Mice; Mice, Nude; Neoplasm Proteins; Ovarian Neoplasms; Peptide Fragments; Receptors, Bombesin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Specific Pathogen-Free Organisms; Xenograft Model Antitumor Assays | 2001 |